RXII - RXI Pharmaceuticals Corporation Tue 24'th Jan 2017
Stock analysis for Tue 24'th Jan 2017 (Updated daily)
Buy candidate since 2017-01-24
RXI Pharmaceuticals Corporation Stock Analysis
RXI Pharmaceuticals Corporation gained 9.00% in the last trading day, rising from USD 0.63 to USD 0.69. The price has fallen in 5 of the last 10 days and is down by -4.17% for this period. Volume also increased in the last day along with the price, which is a positive technical sign, and, in total, 134 052 more shares were traded than the day before. In total, 646 385 shares bought and sold for approximately USD 446 006.
RXI Pharmaceuticals Corporation lies in the lower of a very wide and strong falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at USD 0.39 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -27.4% during the next 3 months and, with 90% probability hold a price between USD 0.28 and USD 1.48 at the end of this period.
RXI Pharmaceuticals Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at USD 0.69 and USD 0.97. A break-up above any of these levels will issue buy signals. Some positive signals were issued as well, and these may have some influence on the near short-term development. A buy signal was issued from a pivot bottom point on Monday January 23, 2017, which indicates further gains until a new top pivot has been found. RXI Pharmaceuticals Corporation has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Relative Strength Index (RSI)
RSI14 is 46 and the stock is currently not being overbought or oversold
Support & Resistance
RXI Pharmaceuticals Corporation finds support from accumulated volume at USD 0.67, USD 0.66, and USD 0.63. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 0.72, USD 0.75 and USD 0.85.
The stock is about to test the resistance from accumulated volume at USD 0.72 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 0.09 between high and low, or 14.62%. For the last week, the stock has had a daily average volatility of 14.50%.
Our recommended stoploss: USD 0.65 (-5.80%) ( based on support and risk)
The stock is within a very wide and strong falling trend and holds several negative signals that may affect the stock in the short-term. We believe, however, today's level to hold a possible buying opportunity and expect the price to be higher at the end of the 3-month period. The careful investor would await further signals. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.